Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
- PMID: 10509516
- DOI: 10.1016/S0140-6736(99)06102-4
Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
Abstract
Highly active antiretroviral therapy (HAART) can induce a characteristic lipodystrophy syndrome of peripheral fat wasting and central adiposity. HIV-1 protease inhibitors are generally believed to be the causal agents, although the syndrome has also been observed with protease-inhibitor-sparing regimens. Here, we postulate that the mitochondrial toxicity of the nucleoside-analogue reverse-transcriptase inhibitors plays an essential part in the development of this lipodystrophy, similar to the role of mitochondrial defects in the development of multiple symmetrical lipomatosis.
Comment in
-
HIV nucleoside analogues: new adverse effects on mitochondria?Lancet. 1999 Sep 25;354(9184):1046-7. doi: 10.1016/s0140-6736(99)00301-3. Lancet. 1999. PMID: 10509488 No abstract available.
-
Toxicity of nucleoside-analogue reverse-transcriptase inhibitors.Lancet. 2000 Mar 25;355(9209):1096. doi: 10.1016/S0140-6736(05)72215-7. Lancet. 2000. PMID: 10744110 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
